Stay updated on Tulisokibart in SSc-ILD Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart in SSc-ILD Clinical Trial page.

Latest updates to the Tulisokibart in SSc-ILD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision marker Revision: v3.6.5 was added, and the Plain Language Summary along with the previous Revision: v3.6.4 note were removed, indicating an update to the page’s versioning and presentation of information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a small update to the page’s revision history rather than a substantive change to study information.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision now shows Revision: v3.6.3 instead of v3.6.0, indicating a version update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check70 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', changing how potential participants should interpret the study page. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a revised label/version note (Intervention/Treatment; Revision: v3.6.0) accompany the update.SummaryDifference0.2%

- Check77 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This appears to be a minor internal update to the page rather than a change to study data or user-facing features.SummaryDifference0.0%

- Check99 days agoChange DetectedThe study record shows updated revision metadata and new date stamps (including the latest revision version and last update dates), indicating ongoing record maintenance for the trial page.SummaryDifference0.2%

Stay in the know with updates to Tulisokibart in SSc-ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart in SSc-ILD Clinical Trial page.